T1	Participants 109 166	patients with open-angle glaucoma or ocular hypertension.
T2	Participants 568 625	patients with open-angle glaucoma or ocular hypertension.
T3	Participants 819 881	randomised 298 patients, of whom 292 (98%) completed the study
